BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 27578360)

  • 1. A New Strategy for Analyzing Time-Series Data Using Dynamic Networks: Identifying Prospective Biomarkers of Hepatocellular Carcinoma.
    Huang X; Zeng J; Zhou L; Hu C; Yin P; Lin X
    Sci Rep; 2016 Aug; 6():32448. PubMed ID: 27578360
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metabolomics Identifies Biomarker Pattern for Early Diagnosis of Hepatocellular Carcinoma: from Diethylnitrosamine Treated Rats to Patients.
    Zeng J; Huang X; Zhou L; Tan Y; Hu C; Wang X; Niu J; Wang H; Lin X; Yin P
    Sci Rep; 2015 Nov; 5():16101. PubMed ID: 26526930
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum Metabolomics to Identify the Liver Disease-Specific Biomarkers for the Progression of Hepatitis to Hepatocellular Carcinoma.
    Gao R; Cheng J; Fan C; Shi X; Cao Y; Sun B; Ding H; Hu C; Dong F; Yan X
    Sci Rep; 2015 Dec; 5():18175. PubMed ID: 26658617
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metabolomic Characterization of Hepatocellular Carcinoma in Patients with Liver Cirrhosis for Biomarker Discovery.
    Di Poto C; Ferrarini A; Zhao Y; Varghese RS; Tu C; Zuo Y; Wang M; Nezami Ranjbar MR; Luo Y; Zhang C; Desai CS; Shetty K; Tadesse MG; Ressom HW
    Cancer Epidemiol Biomarkers Prev; 2017 May; 26(5):675-683. PubMed ID: 27913395
    [No Abstract]   [Full Text] [Related]  

  • 5. A Computational Method of Defining Potential Biomarkers based on Differential Sub-Networks.
    Huang X; Lin X; Zeng J; Wang L; Yin P; Zhou L; Hu C; Yao W
    Sci Rep; 2017 Oct; 7(1):14339. PubMed ID: 29085035
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of 1-Methylnicotinamide as a specific biomarker for the progression of cirrhosis to hepatocellular carcinoma.
    Zhang S; Tuo P; Ji Y; Huang Z; Xiong Z; Li H; Ruan C
    J Cancer Res Clin Oncol; 2024 Jun; 150(6):310. PubMed ID: 38890166
    [TBL] [Abstract][Full Text] [Related]  

  • 7. NMR and LC/MS-based global metabolomics to identify serum biomarkers differentiating hepatocellular carcinoma from liver cirrhosis.
    Liu Y; Hong Z; Tan G; Dong X; Yang G; Zhao L; Chen X; Zhu Z; Lou Z; Qian B; Zhang G; Chai Y
    Int J Cancer; 2014 Aug; 135(3):658-68. PubMed ID: 24382646
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metabolomics study of stepwise hepatocarcinogenesis from the model rats to patients: potential biomarkers effective for small hepatocellular carcinoma diagnosis.
    Tan Y; Yin P; Tang L; Xing W; Huang Q; Cao D; Zhao X; Wang W; Lu X; Xu Z; Wang H; Xu G
    Mol Cell Proteomics; 2012 Feb; 11(2):M111.010694. PubMed ID: 22084000
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Doylestown Algorithm: A Test to Improve the Performance of AFP in the Detection of Hepatocellular Carcinoma.
    Wang M; Devarajan K; Singal AG; Marrero JA; Dai J; Feng Z; Rinaudo JA; Srivastava S; Evans A; Hann HW; Lai Y; Yang H; Block TM; Mehta A
    Cancer Prev Res (Phila); 2016 Feb; 9(2):172-9. PubMed ID: 26712941
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A weighted relative difference accumulation algorithm for dynamic metabolomics data: long-term elevated bile acids are risk factors for hepatocellular carcinoma.
    Zhang W; Zhou L; Yin P; Wang J; Lu X; Wang X; Chen J; Lin X; Xu G
    Sci Rep; 2015 Mar; 5():8984. PubMed ID: 25757957
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnostic Evaluation of Des-Gamma-Carboxy Prothrombin versus α-Fetoprotein for Hepatitis B Virus-Related Hepatocellular Carcinoma in China: A Large-Scale, Multicentre Study.
    Ji J; Wang H; Li Y; Zheng L; Yin Y; Zou Z; Zhou F; Zhou W; Shen F; Gao C
    PLoS One; 2016; 11(4):e0153227. PubMed ID: 27070780
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Early detection of hepatocellular carcinoma co-occurring with hepatitis C virus infection: A mathematical model.
    Zekri AR; Youssef AS; Bakr YM; Gabr RM; Ahmed OS; Elberry MH; Mayla AM; Abouelhoda M; Bahnassy AA
    World J Gastroenterol; 2016 Apr; 22(16):4168-82. PubMed ID: 27122667
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Latent transforming growth factor-beta binding protein-1 in circulating plasma as a novel biomarker for early detection of hepatocellular carcinoma.
    Cao B; Yang L; Rong W; Feng L; Han N; Zhang K; Cheng S; Wu J; Xiao T; Gao Y
    Int J Clin Exp Pathol; 2015; 8(12):16046-54. PubMed ID: 26884881
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum peptide pattern that differentially diagnoses hepatitis B virus-related hepatocellular carcinoma from liver cirrhosis.
    Wang N; Cao Y; Song W; He K; Li T; Wang J; Xu B; Si HY; Hu CJ; Li AL
    J Gastroenterol Hepatol; 2014; 29(7):1544-50. PubMed ID: 24612022
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dysregulated serum metabolites in staging of hepatocellular carcinoma.
    Wang W; Lv J; Chen N; Lou B; Mao W; Wang P; Chen Y
    Clin Biochem; 2018 Nov; 61():7-11. PubMed ID: 30195484
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of serum level of growth differentiation factor 15 with liver cirrhosis and hepatocellular carcinoma.
    Liu X; Chi X; Gong Q; Gao L; Niu Y; Chi X; Cheng M; Si Y; Wang M; Zhong J; Niu J; Yang W
    PLoS One; 2015; 10(5):e0127518. PubMed ID: 25996938
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acetylcarnitine Is a Candidate Diagnostic and Prognostic Biomarker of Hepatocellular Carcinoma.
    Lu Y; Li N; Gao L; Xu YJ; Huang C; Yu K; Ling Q; Cheng Q; Chen S; Zhu M; Fang J; Chen M; Ong CN
    Cancer Res; 2016 May; 76(10):2912-20. PubMed ID: 26976432
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum microRNA profiles as diagnostic biomarkers for HBV-positive hepatocellular carcinoma.
    Zhu HT; Liu RB; Liang YY; Hasan AME; Wang HY; Shao Q; Zhang ZC; Wang J; He CY; Wang F; Shao JY
    Liver Int; 2017 Jun; 37(6):888-896. PubMed ID: 28061012
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Circulating microRNAs as biomarkers for diagnosis of early hepatocellular carcinoma associated with hepatitis B virus.
    Hung CH; Hu TH; Lu SN; Kuo FY; Chen CH; Wang JH; Huang CM; Lee CM; Lin CY; Yen YH; Chiu YC
    Int J Cancer; 2016 Feb; 138(3):714-20. PubMed ID: 26264553
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identifying novel transcript biomarkers for hepatocellular carcinoma (HCC) using RNA-Seq datasets and machine learning.
    Gupta R; Kleinjans J; Caiment F
    BMC Cancer; 2021 Aug; 21(1):962. PubMed ID: 34445986
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.